Graphite Bio Announces Presentation on Phase 1/2 CEDAR Trial of GPH101 in Sickle Cell Disease at Upcoming 63rd ASH Annual Meeting and Exposition
Press release content from Business Wire. The AP news staff was not involved in its creation.
Source: apnews.com